KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,097,554 | -26.5% | 36,061 | -5.7% | 0.01% | -25.0% |
Q2 2023 | $8,292,995 | +26.1% | 38,243 | +5.6% | 0.01% | +20.0% |
Q1 2023 | $6,577,003 | -5.3% | 36,209 | +2.4% | 0.01% | -9.1% |
Q4 2022 | $6,945,293 | -11.2% | 35,345 | +1.7% | 0.01% | -15.4% |
Q3 2022 | $7,819,000 | +104.2% | 34,764 | +14.8% | 0.01% | +116.7% |
Q2 2022 | $3,830,000 | +10.6% | 30,276 | +10.8% | 0.01% | +20.0% |
Q1 2022 | $3,464,000 | -10.7% | 27,317 | -7.7% | 0.01% | 0.0% |
Q4 2021 | $3,879,000 | +9.8% | 29,609 | +2.6% | 0.01% | 0.0% |
Q3 2021 | $3,532,000 | +1.3% | 28,869 | -5.7% | 0.01% | +25.0% |
Q2 2021 | $3,488,000 | +21.8% | 30,603 | +28.5% | 0.00% | 0.0% |
Q1 2021 | $2,864,000 | +17.9% | 23,821 | -0.4% | 0.00% | +33.3% |
Q4 2020 | $2,430,000 | +31.4% | 23,916 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,849,000 | -29.0% | 23,916 | +2.3% | 0.00% | -40.0% |
Q2 2020 | $2,606,000 | +126.8% | 23,383 | +46.5% | 0.01% | +150.0% |
Q1 2020 | $1,149,000 | +113.6% | 15,957 | +123.6% | 0.00% | +100.0% |
Q4 2019 | $538,000 | +363.8% | 7,135 | 0.0% | 0.00% | – |
Q3 2019 | $116,000 | – | 7,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |